The expression levels of mTOR in LN have been shown to vary based on disease severity, cell types, and immune response differences.25 However, future studies should further investigate the interaction between these factors to better understand mTOR’s role in LN and identify more precise targets for clinical treatment. Here, MTOR is linked to lobular neoplasia.